P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: A non-viral intravesical gene therapy for BCG-unresponsive NMIBC with CIS, with or without papillary disease: pivotal phase 2 interim results of detalimogene voraplasmid

P2s: Practice-changing, Paradigm-shifting Clinical Trials in Urology: A non-viral intravesical gene therapy for BCG-unresponsive NMIBC with CIS, with or without papillary disease: pivotal phase 2 interim results of detalimogene voraplasmid

Friday, May 15, 2026 10:50 AM to 11:00 AM · 10 min. (America/New_York)
Hall D
Detail

Registered attendees

Eugene Pietzak
Eugene Pietzak
Urologic OncologistMemorial Sloan Kettering Cancer Center

Log in

See all the content and easy-to-use features by logging in or registering!